Aster Biopharma LLP - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN ABC-0450 Incorporated 11 August 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Converted to LLP Limited Liability Partnership pharma
Contribution obligation
₹50 Lakh
As per LLP agreement
LLP age
4 yrs
Est. 2022
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2023
Balance sheet date
LLP status
Converted and Dissolved
MCA master data
Registrar
Mumbai
ROC office
Incorporated
11 Aug 2022
Date of incorporation

About Aster Biopharma LLP

Data last updated:

Aster Biopharma LLP was a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2022.

The LLP was registered with the Registrar of Companies (ROC), Mumbai, under LLPIN ABC-0450. Its GSTIN is 27ABZFA2494A1Z7 (Maharashtra).

The LLP had a total obligation of contribution of β‚Ή50 Lakh. It was led by designated partners Ruchi Nimish Siria and Agam Lalit Shah.

Its latest statement of accounts is for the year ended 31 March 2023. The registered office was at Mumbai, Maharashtra.

Company details

LLPIN ABC-0450
Incorporation Date 11 August 2022
Total Obligation of Contribution β‚Ή50 Lakh
ROC Mumbai
Company Status Converted and Dissolved

Contact details

Aster Biopharma LLP's registered office is in Mumbai, Maharashtra.

  • Registered Address
    616/1 11th Floor Shree Radhe Empire, Chandavarkar Road, Mumbai, Maharashtra, India – 400092
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers
Comprehensive company report
Aster Biopharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Aster Biopharma LLP

FY 2023 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Aster Biopharma LLP, buy the company report.

Designated partners of Aster Biopharma LLP

Aster Biopharma has 2 designated partners on record. No former designated partners are listed.

Designated Partners (as last reported)
NameDesignationAppointment DateTenureStatus
Ruchi Nimish SiriaDesignated Partner11 Aug 20224 Years 3 MonthsAs last reported
Agam Lalit ShahDesignated Partner11 Aug 20224 Years 3 MonthsAs last reported

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aster Biopharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Aster Biopharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABZFA2494A1Z7MaharashtraActive29 Sep 2022

To see the full GST registrations and return filing status of Aster Biopharma LLP, buy the company report.

Recent activity

Aster Biopharma LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Agam Lalit Shah was appointed as Designated Partner on 11 Aug 2022.

AGM
Aster Biopharma Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Filing
Aster Biopharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Appointed
Agam Lalit Shah was appointed as Designated Partner.
Appointed
Ruchi Nimish Siria was appointed as Designated Partner.
Incorporation
11 Aug 2022
Aster Biopharma Llp was registered on 11 Aug 2022 with Roc Mumbai & aged 4 years 3 months as per MCA records.

Frequently asked questions

Aster Biopharma has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.

Aster Biopharma was a limited liability partnership based in Mumbai, Maharashtra, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2022 and is registered under LLPIN ABC-0450. For the latest details, refer to the successor company.

The LLPIN (Limited Liability Partnership Identification Number) of Aster Biopharma is ABC-0450. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Aster Biopharma had 2 designated partners:

Aster Biopharma was incorporated on 11 August 2022. It is registered with the Registrar of Companies, Mumbai.

The registered office of Aster Biopharma is at 6161 11th Floor Shree Radhe Empire, Chandavarkar Road, Mumbai, Maharashtra, India – 400092.

The latest financial statements of Aster Biopharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2023. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Aster Biopharma is 27ABZFA2494A1Z7, registered in Maharashtra.

Aster Biopharma operated in the pharma industry, in the drug formulation and development segment.

Agam Lalit Shah was appointed as Designated Partner on 11 Aug 2022. Ruchi Nimish Siria was appointed as Designated Partner on 11 Aug 2022.